New findings in prostate and kidney cancer
Neurooncology team uses genetic mapping to target treatment
Primary results from the phase 3 ANDROMEDA study
Largest retrospective study to date confirms randomized trials
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Plasma cell-targeted therapy helps patient with rare condition
Emerging multidisciplinary program seeks better care, outcomes
Largest retrospective series confirms the safety and tolerability
A study of patients with brain metastases treated with SRS
Online tool reveals characteristics that may increase recurrence risk
Psychosocial and downstream effects
Advertisement
Advertisement